ReviewJournal of diabetes science and technology2020

Nanotechnology Approaches to Modulate Immune Responses to Cell-based Therapies for Type 1 Diabetes.

Sydney C Wiggins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.